Mako Surgical’s stock takes a big hit
Stock drops from $41 to $21. Many reasons given: slow sales of RIO systems; utilization rates of existing systems are down; class action suits; and investor restlessness.
The problem of utilization rates, ie, systems sitting idle; of surgeons taking a long time to learn to effectively use the system, is not limited to MAKO. It’s just not talked about publicly.